These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17338730)

  • 1. Successful termination of atrial flutter by ibutilide during pregnancy.
    Burkart TA; Kron J; Miles WM; Conti JB; Gonzalez MD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):283-6. PubMed ID: 17338730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
    Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of ibutilide in children and in patients with congenital heart disease.
    Hoyer AW; Balaji S
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):1003-8. PubMed ID: 17669084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
    Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
    Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm.
    Zarkin GA; Bala MV; Calingaert B; VanderLugt JT
    Am J Manag Care; 1997 Sep; 3(9):1387-94. PubMed ID: 10178487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibutilide-induced cardioversion of atrial fibrillation during pregnancy.
    Kockova R; Kocka V; Kiernan T; Fahy GJ
    J Cardiovasc Electrophysiol; 2007 May; 18(5):545-7. PubMed ID: 17286570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
    Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
    J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
    Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ
    Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibutilide--a new drug for the rapid termination of atrial fibrillation and atrial flutter.
    Kayser SR
    Prog Cardiovasc Nurs; 1997; 12(1):39-43. PubMed ID: 9058463
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
    Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
    Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic conversion of atrial fibrillation and atrial flutter to normal sinus rhythm: the role of ibutilide.
    Katcher MS; Estes NA
    Pharmacotherapy; 1997; 17(1):177-80. PubMed ID: 9017781
    [No Abstract]   [Full Text] [Related]  

  • 12. Brugada syndrome masked by ibutilide treatment in a patient with atrial flutter.
    Pagourelias ED; Fragakis N; Koskinas KC; Geleris P
    Cardiology; 2012; 122(2):89-92. PubMed ID: 22739533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibutilide for cardioversion of atrial flutter: efficacy of a single dose in recent-onset arrhythmias.
    Andò G; Di Rosa S; Rizzo F; Carerj S; Bramanti O; Giannetto M; Arrigo F
    Minerva Cardioangiol; 2004 Feb; 52(1):37-42. PubMed ID: 14765036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ibutilide vs. transoesophageal atrial pacing for the termination of type I atrial flutter.
    Mazza A; Fera MS; Bisceglia I; Bettiol F; Pulignano G; Tanzi P; Gaudio C; Giovannini E
    Europace; 2004 Jul; 6(4):301-6. PubMed ID: 15172654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of ibutilide for cardioversion of recent-onset atrial fibrillation and flutter in elderly.
    Gowda RM; Khan IA; Punukollu G; Mendoza C; Wilbur SL; Vasavada BC; Sacchi TJ
    Am J Ther; 2004; 11(2):95-7. PubMed ID: 14999360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of acute wide QRS complex atrial fibrillation with ibutilide.
    Sobel RM; Dhruva NN
    Am J Emerg Med; 2000 Jul; 18(4):462-4. PubMed ID: 10919540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibutilide therapy in the conversion of atrial flutter in neonates.
    Prasad D; Snyder C; Ashwath R
    Heart Rhythm; 2013 Aug; 10(8):1231-3. PubMed ID: 23624161
    [No Abstract]   [Full Text] [Related]  

  • 18. Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation.
    Doggrell SA; Hancox JC
    Expert Opin Investig Drugs; 2005 May; 14(5):655-69. PubMed ID: 15926871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of ibutilide and propafenone for converting atrial flutter.
    Sun JL; Guo JH; Zhang N; Zhang HC; Zhang P
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):57-64. PubMed ID: 15883757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
    Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
    Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.